4
Changes in Ownership
Janux Therapeutics, Inc. Filed Acc 0001415889-24-024078
Chief Business Officer sold 50,000 shares at $45.96 ($2,297,755)
- Chief Business Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meyer Andrew Hollman Chief Business Officer | 2024-09-27 | Option exercise | +50,000 | $4.21 | $210,500 | 117,592 | D |
| Meyer Andrew Hollman Chief Business Officer | 2024-09-27 | Sale | −50,000 | $45.96 | $2,297,755 | 67,592 | D |
| Derivatives | |||||||
| Meyer Andrew Hollman Chief Business Officer | 2024-09-27 | Option exercise · Stock Option (right to buy) | −50,000 | 100,667 | D | ||
| Open-market sales · 50,000 sh · avg $45.96 · $2,297,755 | |||||||
Loading xslF345X05/form4-09272024_110955.xml…